Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abbate

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Archives of Virology|January 1, 1995
Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cellsO Scheglovitova, V Scanio, S Fais, et al.
Minerva Medica|July 1, 1992
[The determination of sialic acid in cancer patients]M Correale, I Abbate, G Gargano, et al.
Anticancer Research|July 25, 1998
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinomaE Naglieri, V Gebbia, E Durini, et al.
The International Journal of Biological Markers|October 1, 1993
Modification of soluble immunological parameters during treatment with interleukin-2I Abbate, M Correale, M D Musci, et al.
Heliyon|September 10, 2024
Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesotheliomaF Pellicioli, L Sala, F Colonese, et al.
Archives of Virology|January 1, 1995
Host cell antigenic profile acquired by HIV-1 is a marker of its cellular originI Abbate, M R Capobianchi, S Fais, et al.
AIDS (London, England)|April 1, 1995
Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix proteinS Fais, M R Capobianchi, I Abbate, et al.
Transplantation Proceedings|May 23, 2009
Impact of preemptive reduction of immunosuppression with serial monitoring for BK virus replication in renal transplant recipients undergoing short-term evaluationP De Paolis, E Gervasio, M Tedesco, et al.
Cancer Biotherapy|January 1, 1995
Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implicationsM Guida, I Abbate, A Casamassima, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1990
The role of tumour markers in ovarian cancerG Gargano, M Correale, I Abbate, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Archives of Virology|January 1, 1995
Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cellsO Scheglovitova, V Scanio, S Fais, et al.
Minerva Medica|July 1, 1992
[The determination of sialic acid in cancer patients]M Correale, I Abbate, G Gargano, et al.
Anticancer Research|July 25, 1998
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinomaE Naglieri, V Gebbia, E Durini, et al.
The International Journal of Biological Markers|October 1, 1993
Modification of soluble immunological parameters during treatment with interleukin-2I Abbate, M Correale, M D Musci, et al.
Heliyon|September 10, 2024
Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesotheliomaF Pellicioli, L Sala, F Colonese, et al.
Archives of Virology|January 1, 1995
Host cell antigenic profile acquired by HIV-1 is a marker of its cellular originI Abbate, M R Capobianchi, S Fais, et al.
AIDS (London, England)|April 1, 1995
Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix proteinS Fais, M R Capobianchi, I Abbate, et al.
Transplantation Proceedings|May 23, 2009
Impact of preemptive reduction of immunosuppression with serial monitoring for BK virus replication in renal transplant recipients undergoing short-term evaluationP De Paolis, E Gervasio, M Tedesco, et al.
Cancer Biotherapy|January 1, 1995
Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implicationsM Guida, I Abbate, A Casamassima, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1990
The role of tumour markers in ovarian cancerG Gargano, M Correale, I Abbate, et al.
Pageof 7